Gregory Renza
Stock Analyst at Truist Securities
(4.05)
# 487
Out of 5,090 analysts
239
Total ratings
40.98%
Success rate
16.06%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Assumes: Buy | $812 → $798 | $718.36 | +11.09% | 1 | Nov 24, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $2.40 | +400.00% | 7 | Nov 24, 2025 | |
| NRIX Nurix Therapeutics | Assumes: Buy | $23 → $30 | $18.09 | +65.84% | 12 | Nov 24, 2025 | |
| GILD Gilead Sciences | Assumes: Buy | $145 → $140 | $121.22 | +15.49% | 1 | Nov 24, 2025 | |
| AMGN Amgen | Assumes: Hold | $298 → $318 | $329.89 | -3.60% | 18 | Nov 24, 2025 | |
| XNCR Xencor | Initiates: Buy | $29 | $17.30 | +67.63% | 10 | Nov 24, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | $41 | $32.02 | +28.04% | 12 | Nov 24, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $11 | $8.55 | +28.65% | 7 | Nov 24, 2025 | |
| NUVL Nuvalent | Initiates: Buy | $140 | $109.60 | +27.74% | 1 | Nov 24, 2025 | |
| MNKD MannKind | Initiates: Buy | $9 | $5.68 | +58.45% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $59 | $35.87 | +64.48% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $8.90 | +57.30% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $62 | $43.30 | +43.19% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $7.07 | +41.44% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $322.90 | +23.88% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $32.88 | +55.11% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $27.73 | +15.40% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $114.51 | +22.26% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $35 | $220.36 | -84.12% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $27.44 | -5.25% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $3.29 | +143.16% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $2.07 | +141.55% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $44.36 | -9.83% | 10 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $169.70 | +1.36% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $79.99 | -53.12% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $10.56 | +13.64% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $10.36 | +35.14% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $23.99 | -24.97% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $1.71 | +2,707.02% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $8.81 | +127.01% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.82 | +1,841.98% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $17.56 | +925.06% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $1.06 | +7,447.17% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.47 | +6,255.93% | 3 | Jun 2, 2020 |
Regeneron Pharmaceuticals
Nov 24, 2025
Assumes: Buy
Price Target: $812 → $798
Current: $718.36
Upside: +11.09%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $2.40
Upside: +400.00%
Nurix Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $18.09
Upside: +65.84%
Gilead Sciences
Nov 24, 2025
Assumes: Buy
Price Target: $145 → $140
Current: $121.22
Upside: +15.49%
Amgen
Nov 24, 2025
Assumes: Hold
Price Target: $298 → $318
Current: $329.89
Upside: -3.60%
Xencor
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $17.30
Upside: +67.63%
Viridian Therapeutics
Nov 24, 2025
Initiates: Buy
Price Target: $41
Current: $32.02
Upside: +28.04%
Nuvation Bio
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $8.55
Upside: +28.65%
Nuvalent
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $109.60
Upside: +27.74%
MannKind
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $5.68
Upside: +58.45%
Nov 24, 2025
Initiates: Buy
Price Target: $59
Current: $35.87
Upside: +64.48%
Nov 24, 2025
Initiates: Buy
Price Target: $14
Current: $8.90
Upside: +57.30%
Nov 24, 2025
Initiates: Buy
Price Target: $62
Current: $43.30
Upside: +43.19%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $7.07
Upside: +41.44%
Nov 24, 2025
Initiates: Buy
Price Target: $400
Current: $322.90
Upside: +23.88%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $32.88
Upside: +55.11%
Nov 24, 2025
Initiates: Buy
Price Target: $32
Current: $27.73
Upside: +15.40%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $114.51
Upside: +22.26%
May 23, 2025
Maintains: Outperform
Price Target: $31 → $35
Current: $220.36
Upside: -84.12%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $27.44
Upside: -5.25%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $3.29
Upside: +143.16%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $2.07
Upside: +141.55%
May 14, 2025
Reiterates: Outperform
Price Target: $40
Current: $44.36
Upside: -9.83%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $169.70
Upside: +1.36%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $79.99
Upside: -53.12%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $10.56
Upside: +13.64%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $10.36
Upside: +35.14%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $23.99
Upside: -24.97%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $1.71
Upside: +2,707.02%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $8.81
Upside: +127.01%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.82
Upside: +1,841.98%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $17.56
Upside: +925.06%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $1.06
Upside: +7,447.17%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.47
Upside: +6,255.93%